GlassScriptPhysician profile
Deena Hakim
NPI 1184449522
$507.26
in general payments reported to CMS, 2019-2025
13 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $103 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $98.78 | 2025 | |
| Genzyme Corporation | $67.20 | 2024 | |
| Ucb, INC. | $62.25 | 2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $51.16 | 2024-2025 | Libtayo, Dupixent |
| Abbvie INC. | $42.15 | 2025 | |
| Lilly USA, LLC | $35.30 | 2025 | Ebglyss, Taltz |
| Pfizer INC. | $29.31 | 2025 | |
| Organon LLC | $24.54 | 2025 | Hadlima |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.49 | 2025 | Spevigo |
| Sun Pharmaceutical Industries INC. | $22.26 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $20.07 | 2025 | Sotyktu |
| Almirall LLC | $15.74 | 2025 | Klisyri |
| Leo Pharma INC. | $15.01 | 2025 | Anzupgo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deena Hakim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.